Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09RND
|
||||
| Former ID |
DCL001184
|
||||
| Drug Name |
EZN-4176
|
||||
| Drug Type |
Antisense drug
|
||||
| Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Phase 1 | [551623] | ||
| Company |
Santaris Pharma A/S
|
||||
| Target and Pathway | |||||
| Target(s) | mRNA of androgen receptor | Target Info | [551623] | ||
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Coregulation of Androgen receptor activity | |||||
| Regulation of Androgen receptor activity | |||||
| Nongenotropic Androgen signaling | |||||
| Regulation of nuclear beta catenin signaling and target gene transcription | |||||
| FOXA1 transcription factor network | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.